Kindstar Globalgene Technology, Inc. (HK:9960) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kindstar Globalgene Technology, Inc. reported a decrease in revenue and net income for the first half of 2024 compared to the previous year, with a notable absence of COVID-19-related testing revenue. Gross profit margin declined due to investment in new products and expansion, contributing to a significant 75.8% drop in net income and a decrease in net margin from 8.8% to 2.2%.
For further insights into HK:9960 stock, check out TipRanks’ Stock Analysis page.